- Home
- CDNA vs ASPN Comparison
CDNA vs ASPN Comparison
Compare CDNA & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- ASPN
- Stock Information
- Founded
- CDNA 1998
- ASPN 2001
- Country
- CDNA United States
- ASPN United States
- Employees
- CDNA N/A
- ASPN N/A
- Industry
- CDNA Medical Specialities
- ASPN RETAIL: Building Materials
- Sector
- CDNA Health Care
- ASPN Consumer Discretionary
- Exchange
- CDNA Nasdaq
- ASPN Nasdaq
- Market Cap
- CDNA 712.2M
- ASPN 573.2M
- IPO Year
- CDNA 2014
- ASPN 2014
- Fundamental
- Price
- CDNA $18.03
- ASPN $3.08
- Analyst Decision
- CDNA Buy
- ASPN Buy
- Analyst Count
- CDNA 7
- ASPN 6
- Target Price
- CDNA $26.00
- ASPN $13.00
- AVG Volume (30 Days)
- CDNA 1.2M
- ASPN 3.5M
- Earning Date
- CDNA 11-04-2025
- ASPN 11-06-2025
- Dividend Yield
- CDNA N/A
- ASPN N/A
- EPS Growth
- CDNA N/A
- ASPN N/A
- EPS
- CDNA 1.22
- ASPN N/A
- Revenue
- CDNA $357,998,000.00
- ASPN $352,852,000.00
- Revenue This Year
- CDNA $12.73
- ASPN N/A
- Revenue Next Year
- CDNA $11.90
- ASPN $8.56
- P/E Ratio
- CDNA $14.75
- ASPN N/A
- Revenue Growth
- CDNA 14.46
- ASPN N/A
- 52 Week Low
- CDNA $10.96
- ASPN $2.92
- 52 Week High
- CDNA $26.37
- ASPN $15.38
- Technical
- Relative Strength Index (RSI)
- CDNA 67.03
- ASPN 24.90
- Support Level
- CDNA $15.60
- ASPN $2.92
- Resistance Level
- CDNA $17.09
- ASPN $3.20
- Average True Range (ATR)
- CDNA 1.02
- ASPN 0.32
- MACD
- CDNA 0.15
- ASPN -0.10
- Stochastic Oscillator
- CDNA 95.64
- ASPN 3.19
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.